XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Choosing the right accounts and locations for index funds can reduce taxable distributions and improve net returns over time.
15,987 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
A U.S. equity ETF with about $11 billion in assets is beating the broad market by favoring profitable, attractively v...
In a dividend aristocrats shaky market, Coca-Cola, Procter & Gamble, Johnson & Johnson, McDonald's, and Colgate-Palmo...
January data shows the fed's favored inflation gauge staying elevated, underscoring persistent price pressures as pol...
Stocks reversed a sharp rally as fear returned to the market. The S&P 500’s latest surge gave way overnight, with fut...
Bitcoin dropped below the $67,000 level as U.S. Treasury yields climbed toward yearly highs, igniting a risk-off shak...
Ethereum is the lone red stake among the top-10 cryptos this week, while Bitcoin and other large caps post gains as i...
May data show rising inflation pressures even as growth slows, with renewed Middle East tensions fanning fears of sta...
April data from the Mortgage Bankers Association show a modest uptick in mortgage payments, nudging homebuyer afforda...
April data show the fed's favored inflation gauge rose modestly, keeping inflation well above the 2% target. Analysts...
As inflation stays stubborn, the latest CPI data point toward a larger COLA for 2027, though 2026 benefits are alread...
Tech-led gains paced a Nasdaq climb as investors reassessed hawkish Fed signals. The index rose, while traders weighe...